Performance of ASND Ascendis Pharma AS | 59.6% in 12m
Compare ASND with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Ascendis Pharma AS with its related Sector/Index XBI
Performance Duell ASND vs XBI
| TimeFrame | ASND | XBI |
|---|---|---|
| 1 Day | -1.22% | -1.05% |
| 1 Week | -4.41% | -0.08% |
| 1 Month | -8.91% | -9.83% |
| 3 Months | 6.55% | -3.21% |
| 6 Months | 55.0% | 27.79% |
| 12 Months | 59.6% | 3.13% |
| YTD | 8.55% | -6.22% |
| Rel. Perf. 1m | 0.25 | |
| Rel. Perf. 3m | 1.62 | |
| Rel. Perf. 6m | 1.92 | |
| Rel. Perf. 12m | 4.98 |
Is Ascendis Pharma AS a good stock to buy?
No, based on ValueRay Fundamental Analyses, Ascendis Pharma AS (NASDAQ:ASND) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -59.67 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ASND as of May 2024 is 134.14. This means that ASND is currently overvalued and has a potential downside of -3.11% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ASND as of May 2024 is 134.14. This means that ASND is currently overvalued and has a potential downside of -3.11% (Sold with Premium).
Is ASND a buy, sell or hold?
- Strong Buy: 8
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 0
Values above 0%: ASND is performing better - Values below 0%: ASND is underperforming
Compare ASND with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.68% | -5.05% | 34.12% | 37.04% |
| US NASDAQ 100 | QQQ | -4.30% | -4.33% | 33.53% | 26.94% |
| US Dow Jones Industrial 30 | DIA | -2.62% | -4.61% | 39.52% | 46.35% |
| German DAX 40 | DBXD | -3.20% | -6.91% | 33.98% | 46.14% |
| UK FTSE 100 | ISFU | -6.37% | -11.46% | 38.11% | 50.23% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -7.08% | -9.36% | 53.56% | 72.37% |
| Hongkong Hang Seng | HSI | -9.59% | -11.40% | 56.99% | 79.30% |
| Japan Nikkei 225 | EXX7 | -4.04% | -2.89% | 38.07% | 40.64% |
| India NIFTY 50 | INDA | -5.06% | -10.58% | 33.94% | 32.05% |
| Brasil Bovespa | EWZ | -3.99% | -6.40% | 47.08% | 42.18% |
ASND Ascendis Pharma AS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.78% | -3.53% | 34.09% | 28.38% |
| Consumer Discretionary | XLY | -6.20% | -5.13% | 39.09% | 38.71% |
| Consumer Staples | XLP | -4.60% | -8.58% | 42.08% | 59.33% |
| Energy | XLE | -1.71% | -7.24% | 43.28% | 44.65% |
| Financial | XLF | -2.54% | -5.26% | 29.20% | 35.42% |
| Health Care | XLV | -3.72% | -4.72% | 41.42% | 53.33% |
| Industrial | XLI | -3.15% | -6.13% | 30.40% | 36.70% |
| Materials | XLB | -4.81% | -4.55% | 37.25% | 47.25% |
| Real Estate | XLRE | -3.56% | -2.09% | 43.76% | 59.38% |
| Technology | XLK | -3.97% | -2.89% | 34.88% | 28.49% |
| Utilities | XLU | -5.01% | -11.19% | 41.21% | 59.69% |
| Aerospace & Defense | XAR | -5.05% | -6.71% | 36.39% | 40.41% |
| Biotech | XBI | -4.33% | 0.92% | 27.22% | 56.47% |
| Homebuilder | XHB | -3.44% | -2.07% | 11.23% | 13.05% |
| Retail | XRT | -2.70% | -0.41% | 31.88% | 40.37% |
Does Ascendis Pharma AS outperform its market, is ASND a Sector Leader?
Yes, over the last 12 months Ascendis Pharma AS (ASND) made 59.60%, while its related Sector, the SPDR S&P Biotech (XBI) made 3.13%.
Over the last 3 months ASND made 6.55%, while XBI made -3.21%.
Yes, over the last 12 months Ascendis Pharma AS (ASND) made 59.60%, while its related Sector, the SPDR S&P Biotech (XBI) made 3.13%.
Over the last 3 months ASND made 6.55%, while XBI made -3.21%.
| Period | ASND | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -8.91% | -9.83% | -3.86% |
| 3 Months | 6.55% | -3.21% | 4.28% |
| 12 Months | 59.60% | 3.13% | 22.56% |